Published in AIDS Weekly, October 18th, 1999
The data were presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in San Francisco, California, September 26-29, 1999.
"ABT-378/r demonstrated activity against HIV and a promising tolerability profile in both studies," said Joseph Eron, MD, University of North Carolina at Chapel Hill (UNC-CH), and an investigator in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.